Machado Patrick

CIK 000131121018 companiesSAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001311210

Recent Transactions

50 trades

Disposition to Issuer
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2025-12-09−3,360→ 0 total
Disposition to Issuer
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2025-12-09−4,500→ 0 total
Disposition to Issuer
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2025-12-09−13,820→ 0 total
Disposition to Issuer
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2025-12-09−6,476→ 0 total
Disposition to Issuer
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2025-12-09−3,500→ 0 total
Disposition from Tender
Adverum Biotechnologies, Inc.
Common Stock
2025-12-09−8,818→ 0 total
Disposition to Issuer
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2025-12-09−1,500→ 0 total
Disposition to Issuer
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2025-12-09−5,250→ 0 total
Disposition to Issuer
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2025-12-09−1,000→ 0 total
Disposition to Issuer
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2025-12-09−13,590→ 0 total
Disposition to Issuer
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2025-12-09−3,000→ 0 total
Award
ALUMIS INC.$ALMS
Stock Option (Right to Buy)
2025-07-30+49,800→ 49,800 total
Award
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2025-06-17+3,140→ 3,140 total
Award
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2025-06-17+10,450→ 10,450 total
Award
Arcus Biosciences, Inc.$RCUS
Stock Option (Right to Buy)
2025-06-10+38,300→ 38,300 total
Award
Arcus Biosciences, Inc.$RCUS
Common Stock
2025-06-10+13,300→ 38,600 total
Award
Xenon Pharmaceuticals Inc.$XENE
Share Option (Right to Buy)
2025-06-05+17,012→ 17,012 total
Award
Xenon Pharmaceuticals Inc.$XENE
Restricted Share Units
2025-06-05+2,645→ 2,645 total
Award
ALUMIS INC.$ALMS
Common Stock
2025-05-21+7,064→ 7,064 total
Award
ALUMIS INC.$ALMS
Stock Option (Right to Buy)
2025-05-21+11,189→ 11,189 total
Award
ALUMIS INC.$ALMS
Stock Option (Right to Buy)
2025-05-21+44,364→ 44,364 total
Award
ALUMIS INC.$ALMS
Stock Option (Right to Buy)
2025-05-21+41,499→ 41,499 total
Disposition to Issuer
ACELYRIN, Inc.
Director Stock Option (right to buy)
2025-05-21−40,567→ 0 total
Disposition to Issuer
ACELYRIN, Inc.
Director Stock Option (right to buy)
2025-05-21−23,243→ 0 total
Disposition to Issuer
ACELYRIN, Inc.
Director Stock Option (right to buy)
2025-05-21−28,675→ 0 total
Disposition to Issuer
ACELYRIN, Inc.
Director Stock Option (right to buy)
2025-05-21−92,158→ 0 total
Disposition to Issuer
ACELYRIN, Inc.
Director Stock Option (right to buy)
2025-05-21−86,206→ 0 total
Award
ALUMIS INC.$ALMS
Stock Option (Right to Buy)
2025-05-21+13,804→ 13,804 total
Award
ALUMIS INC.$ALMS
Stock Option (Right to Buy)
2025-05-21+19,528→ 19,528 total
Disposition to Issuer
ACELYRIN, Inc.
Common Stock
2025-05-21−14,675→ 0 total
Disposition to Issuer
ALUMIS INC.$ALMS
Stock Option (Right to Buy)
2024-07-01−38,000→ 0 total
Award
ALUMIS INC.$ALMS
Stock Option (Right to Buy)
2024-07-01+38,000→ 38,000 total
Award
ALUMIS INC.$ALMS
Stock Option (Right to Buy)
2024-06-27+38,000→ 38,000 total
Award
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2024-06-17+3,300→ 3,300 total
Award
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2024-06-17+10,520→ 10,520 total
Award
ACELYRIN, Inc.
Director Stock Option (right to buy)
2024-06-07+92,158→ 92,158 total
Award
Arcus Biosciences, Inc.$RCUS
Stock Option (Right to Buy)
2024-06-06+24,000→ 24,000 total
Award
Arcus Biosciences, Inc.$RCUS
Common Stock
2024-06-06+8,400→ 25,300 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2024-06-05+15,542→ 15,542 total
Other
ACELYRIN, Inc.
Common Stock
2023-10-04+14,675→ 14,675 total
Award
Arcus Biosciences, Inc.$RCUS
Stock Option (Right to Buy)
2023-06-15+19,500→ 19,500 total
Award
Arcus Biosciences, Inc.$RCUS
Common Stock
2023-06-15+6,800→ 16,900 total
Award
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2023-06-09+12,500→ 52,500 total
Award
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2023-06-09+40,000→ 40,000 total
Award
CHIMERIX INC
Stock Option (Right to Buy)
2023-06-09+60,000→ 60,000 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2023-06-02+18,475→ 18,475 total
Other
ACELYRIN, Inc.
Director Stock Option (right to buy)
2023-05-09+86,206→ 86,206 total
Other
ACELYRIN, Inc.
Director Stock Option (right to buy)
2023-05-09+40,567→ 40,567 total
Other
ACELYRIN, Inc.
Director Stock Option (right to buy)
2023-05-09−40,567→ 0 total
Other
ACELYRIN, Inc.
Director Stock Option (right to buy)
2023-05-09+23,243→ 23,243 total

Companies

Recent Filings

Address

C/O MEDIVATION, INC. 201 SPEAR STREET, 3RD FLOOR

SAN FRANCISCO, CA, 94105

View on SEC.gov